The American Pediatric Society selects Dr. Glenn Flores as the recipient of the 2024 David G. Nichols Health Equity Award
A distinguished pediatrics leader is recognized for his significant contributions to child and adolescent health, well-being, and equity.
2023-11-08
(Press-News.org) The American Pediatric Society (APS) is pleased to announce Glenn Flores, MD, as the 2024 David G. Nichols Health Equity Award recipient.
The David G. Nichols Health Equity Award, administered by the APS and endowed by the American Board of Pediatrics (ABP) Foundation, was created to recognize demonstrated excellence in advancing child and adolescent health, well-being, and equity through quality improvement, advocacy, practice, or research. This award recognizes Dr. Flores’ outstanding contributions to advancing child and adolescent health, well-being, and equity and the far-reaching impact of his work. The award will be presented to Dr. Flores during the APS Presidential Plenary at the Pediatric Academic Societies 2024 Meeting in Toronto, Canada, May 2 – May 6.
Dr. Glenn Flores’ commitment to achieving equity and eliminating disparities for the most underserved patients and families started as a resident and junior faculty when he founded the Pediatric Latino Clinic at Boston Medical Center to better serve the Latino community by providing linguistic and culturally relevant healthcare. In the decades since, Dr. Flores has continued to address our nation’s gaps in healthcare for children and youth through his research, advocacy, and mentoring efforts. His past research includes a systematic review of the impact of medical interpreter services on healthcare quality and an exhaustive critical review of barriers to healthcare access for Latino children. Dr. Flores’ advocacy achievements include being an invited speaker and panelist for the US Surgeon General’s Workshop on Improving Health Literacy. He also drafted 2018 legislation signed into law by Congress and the President as part of CHIP reauthorization which makes organizations that use parent mentors eligible to receive $120 million in CMS grants for Medicaid and CHIP outreach and enrollment; there are now CMS-funded parent-mentor programs in 11 states and the Cherokee Nation. Finally, Dr. Flores has been the primary mentor for an impressive 72 mentees, most of whom have been underrepresented minorities in medicine.
"Dr. Flores embodies the essence of the David G. Nichols Health Equity Award, continuing the legacy of Dr. Nichols’ unwavering commitment to health equity and diversity in pediatric care," said Dr. John A. Barnard, MD, Interim President and CEO of the American Board of Pediatrics. Dr. Flores’ lifelong dedication to eliminating disparities and fostering equity for underserved children and families is both inspiring and transformative.”
“From his pioneering work in establishing the Pediatric Latino Clinic at Boston Medical Center to his influential research and advocacy efforts, Dr. Flores has been a beacon of hope and progress. His leadership of the Research in Academic Pediatrics Initiative on Diversity (RAPID) underscores his commitment to nurturing the next generation of diverse pediatric leaders. We are honored to celebrate Dr. Flores as a testament to the enduring impact of Dr. Nichols’ vision and values.”
APS President, Dr. Michael DeBaun, commented, “Dr. Flores has had a multi-generational impact on mentoring the next generation of pediatric physician-scientists and leaders. In 2010, Dr. Flores was the initiator and has been the only director of the Research in Academic Pediatrics Initiative on Diversity (RAPID). RAPID recently received its second competitive renewal from NIDDK for Years 11-15. RAPID has been associated with an astounding 86% increase in APA’s racial/ethnic diversity. RAPID Scholars have generated multiple national conference publications and presentations and received NIH K and AMFDP awards, R01s, and major FDA funding. The RAPID Annual Conference brings in underrepresented minorities in medicine investigations nationwide, spanning the spectrum from residents to mid-level faculty. Glenn has carefully forged RAPID partnerships with the Pediatric Infectious Diseases Society, the American Board of Pediatrics, the American Pediatric Society, and Mead Johnson.”
“On a personal note, I have known Glenn for over 20 years. He has carved out a path for discovery and advocacy that few thought was feasible and many thought was not worthwhile. He has been steadfast in his mission to provide meaningful opportunities for Black and Brown pediatricians who aspire to be physician-scientists, physician leaders, or both.”
Dr. Flores completed his bachelor’s degree at Harvard University and received his medical degree from the University of California, San Francisco, School of Medicine. His pediatric residency was at The New York Hospital-Cornell Medical Center, followed by his Yale University School of Medicine fellowship. He is Professor and Chair of Pediatrics and Senior Associate Dean of Child Health at the University of Miami Miller School of Medicine, and Physician-in-Chief at Holtz Children’s Hospital in the Jackson Health System.
Please visit the APS website for more information about Dr. Flores and the APS David G. Nichols Health Equity Award.
###
About the American Pediatric Society
The American Pediatric Society (APS) is a nonprofit organization founded in 1888 as the first pediatric society in North America. The mission of the APS is to shape the future of academic pediatrics through the engagement of distinguished child-health leaders to represent the full diversity within the field. The 1,800-plus members of APS are recognized leaders of extraordinary achievement who work together to shape the future of academic pediatrics. For more information, please visit aps1888.org and follow us on Facebook and Twitter.
Media Contact:
Lisa Thompson
Association Director
American Pediatric Society
(346) 980-9707
lthompson@aps1888.org
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-11-08
Under the ocean’s surface, marine organisms are constantly releasing invisible molecules. Some of the chemical clues reveal which creatures are nearby, while others could be used someday as medications. Now, researchers in ACS Central Science report a proof-of-concept device that “sniffs” seawater, trapping dissolved compounds for analyses. The team showed that the system could easily concentrate molecules that are present in underwater caves and holds promise for drug discovery in fragile ecosystems, including coral reefs.
A ...
2023-11-08
By rapidly reversing the effects of an opioid overdose, naloxone saves lives ― if it’s available at the right time. To eliminate this element of chance, researchers are exploring ways to have the medication available in the body before it’s needed. In a proof-of-concept in ACS’ Nano Letters, a team has designed injectable nanoparticles that released naloxone when triggered by blue light. In experiments with mice, this system was activated a month after injection.
Since it began more than two decades ago, the opioid epidemic has taken an enormous toll on people’s lives. In 2022 ...
2023-11-08
In patients with systemic sclerosis (SSc), a rare connective tissue disease, interstitial lung disease contributes to 35 percent of deaths. Published recently in the American Journal of Respiratory and Critical Care Medicine, the latest American Thoracic Society Clinical Practice Guideline makes a number of recommendations. One recommendation expands antifibrotic treatment to all patients with systemic sclerosis associated with ILD (SSc-ILD), not just those with progressive disease.
Watch the explainer video.
Lead guidelines chair and editor, Ganesh Raghu, M.D., ATSF, noted the timeliness of the recommendations given the many immune ...
2023-11-08
Central diabetes insipidus (CDI), a rare condition involving the destruction or degeneration of neurons of the hypothalamic-posterior pituitary in the brain, has several likely underlying clinical causes. Patients with CDI experience excessive thirst and excessive urine production, owing to the decreased secretion of AVP. Moreover, in children and young adults with CDI, a malignant tumor known as a 'germinoma' may develop later in life. The diagnosis of these tumors is challenging, because biopsy in intracranial lesions is difficult.
Lymphocytic infundibulo-neurohypophysitis (LINH) or ...
2023-11-08
General anesthesia evokes a dual mystery: How does it disrupt consciousness, including sensory perception, and what might that say about the nature of consciousness. A new study led by researchers at The Picower Institute for Learning and Memory at MIT provides evidence in animals that consciousness depends on properly synchronized communication across the brain’s cortex and that the anesthetic drug propofol cancels sensory processing by cutting it off.
In the Journal of Cognitive Neuroscience, researchers report clear evidence that in anesthetized animals, ...
2023-11-08
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether cancer will come back after treatment than analysis of the tumors themselves, according to new research led by NYU Langone Health and its Perlmutter Cancer Center.
The new study focuses on lung adenocarcinoma, a cancer that forms in alveolar epithelial cells and accounts for about a third of all lung cancers in the United States, according to the U.S. Centers for Disease Control and Prevention. Most patients are cured if tumors are surgically removed early in the disease’s progression, but residual ...
2023-11-08
UCLA scientists have developed a new method to engineer more powerful immune cells that can potentially be used for “off-the-shelf” cell therapy to treat challenging cancers.
“Off-the-shelf” cell therapy, also known as allogenic therapy, uses immune cells derived from healthy donors instead of patients. The approach can bring cell therapies, like chimeric antigen receptor (CAR) T cell therapy, to more patients in a timelier manner, which is one of the major barriers in getting these life-saving treatments to patients.
“Time is often of the essence when it comes to treating people with advanced cancers,” said Lili Yang, associate professor ...
2023-11-08
A research team in Japan, led by Nagoya University’s Akira Yokoi, has developed an innovative technique using cellulose nanofiber (CNF) sheets derived from wood cellulose to capture extracellular vesicles (EVs) from fluid samples and even organs during surgery. EVs are small structures from cancerous cells that play a crucial role in cell-to-cell communication. Extracting and analyzing EVs using this new technology has the potential to revolutionize early cancer diagnosis and open the door to personalized medicine. The researchers published their findings in Nature Communications.
Cancer is notorious for its poor prognosis and in many cases goes undetected until its ...
2023-11-08
Results from a new clinical trial suggest that a group of brain regions known as the “salience network” is activated after a drug is taken intravenously, but not when that same drug is taken orally. When drugs enter the brain quickly, such as through injection or smoking, they are more addictive than when they enter the brain more slowly, such as when they are taken orally. However, the brain circuits underlying these differences are not well understood. This study offers new information that helps explain what may be causing this difference.
The study was published in Nature Communications and led by researchers at the National Institute on Drug Abuse (NIDA) and the National ...
2023-11-08
The last 40 years have witnessed a deep transformation in our views of animal development. From seeing development a multicellular black box where over time a mass of cells acquires shape to form organs and tissues, we now have a detailed account of this process in terms of gene expression, multicellular activity, and morphogenesis.
This new point of view has raised questions about the relationships between genes, cells, and organisms. These questions are impacting our thinking about evolution, ...
LAST 30 PRESS RELEASES:
[Press-News.org] The American Pediatric Society selects Dr. Glenn Flores as the recipient of the 2024 David G. Nichols Health Equity Award
A distinguished pediatrics leader is recognized for his significant contributions to child and adolescent health, well-being, and equity.
